Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Strong Wakamoto
- Development stage
- Unknown
- Lead developer
- Wakamoto
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Strong Wakamoto is a long-established Japanese gastrointestinal remedy formulated to provide three main functions: digestive aid, intestinal regulation, and nutritional supplementation. Developed by Wakamoto Pharmaceutical, the product is classified as a designated quasi-drug in Japan. It is formulated with three primary naturally derived active components: Aspergillus oryzae NK culture powder (a proprietary koji mold strain that produces digestive enzymes like amylase and protease to assist in food breakdown), a lactic acid bacteria culture powder (specifically Streptococcus faecalis, which helps suppress harmful intestinal flora and regulate bowel movements), and dried brewer's yeast (which provides essential amino acids, vitamins, and minerals to combat physical fatigue and support overall nutrition). Strong Wakamoto is indicated for the treatment of gastrointestinal disorders, including indigestion, stomach heaviness, abdominal bloating, constipation, and loose stools, as well as for nutritional fortification.
- Brand names
- Strong Wakamoto
- Other names
- Kyoryoku WakamotoWakamoto TabletWakamoto Tablets
Beyond the preview
Go deeper on Strong Wakamoto.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Strong Wakamoto.